Cornerstone Advisory’s iShares Biotechnology ETF IBB Stock Holding History

Cornerstone Advisory’s Portfolio IBB Stock Details IBB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q3	–	Sell	-2,535	Closed	-$322K	–	215
2023 Q2	$322K	Hold	2,535	–	–	0.06%	167
2023 Q1	$327K	Sell	2,535 -1,342	-35%	-$176K	0.06%	164
2022 Q4	$509K	Buy	3,877 +695	+22%	+$89.8K	0.1%	125
2022 Q3	$372K	Sell	3,182 -182	-5%	-$22.6K	0.08%	136
2022 Q2	$396K	Sell	3,364 -2,275	-40%	-$270K	0.09%	130
2022 Q1	$735K	Sell	5,639 -846	-13%	-$110K	0.11%	140
2021 Q4	$990K	Buy	+6,485	New	+$1M	0.14%	106
2019 Q3	–	Sell	-4,150	Closed	-$453K	–	162
2019 Q2	$453K	Sell	4,150 -400	-9%	-$42.5K	0.1%	108
2019 Q1	$509K	Buy	4,550 +300	+7%	+$32.9K	0.11%	106
2018 Q4	$410K	Buy	+4,250	New	+$451K	0.11%	104

Other funds holding IBB

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Citigroup New York $235B AUM 32.99% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

BNP Paribas Financial Markets Paris, France $206B AUM 31.61% 1-Year Est. Return

Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return

Commerce Bank Kansas City, Missouri $20.7B AUM 23.76% 1-Year Est. Return

Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

Cornerstone Advisory's IBB Position: Q3 2023 in Review

Cornerstone Advisory sold out of iShares Biotechnology ETF (IBB) in Q3 2023, closing a stake of 2,535 shares — an estimated $322K sold.

Cornerstone Advisory first reported a position in IBB in Q4 2018 and held it in 10 quarters. The position peaked at $990K in Q4 2021. 832 funds tracked by Wall St. Rank hold IBB as of Q3 2023.

Cornerstone Advisory reported no remaining iShares Biotechnology ETF position as of Q3 2023 after selling out during the quarter.
Cornerstone Advisory sold 2,535 iShares Biotechnology ETF shares in Q3 2023, an estimated $322K.
Cornerstone Advisory first reported a position in iShares Biotechnology ETF in Q4 2018 and held it in 10 quarters.
Cornerstone Advisory's iShares Biotechnology ETF position peaked at $990K in Q4 2021.
832 funds tracked by Wall St. Rank held iShares Biotechnology ETF as of Q3 2023.

Based on Cornerstone Advisory's 13F filing for Q3 2023, filed 14 Nov 2023.